SIEGALL CLAY B - Insider Non-Derivative Transactions at Immunome Inc. (IMNM) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 21, 2024, SIEGALL CLAY B's relationship to Immunome Inc. (IMNM) is Director,Officer (President and CEO), and currently has 419,636 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other IMNM insiders.
Data Source: SEC.
SIEGALL CLAY B - Insider Non-Derivative Transactions of IMNM Common Stock
SIEGALL CLAY B - Insider Non-Derivative Transactions at IMNM
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 22, 2024 | P -- (Common Stock) | 20434 | 13.78 | 419636 |
| May 21, 2024 | P -- (Common Stock) | 79566 | 13.91 | 399202 |
| Oct 3, 2023 | P -- (Common Stock) | 169204 | 5.91 | 319636 |